Blood Coagulation Concept

subject area of

• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Journal Articles
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Journal Articles
• 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• 4D intravital imaging identifies platelets as the predominant cellular procoagulant surface in a mouse hemostasis model  Journal Articles
• A Control Switch for Prothrombinase  Journal Articles
• A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep  Journal Articles
• A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization  Journal Articles
• A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era  Journal Articles
• A Protease TAMER: a nucleic acid‐based anticoagulant  Journal Articles
• A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran  Journal Articles
• A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation  Journal Articles
• A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury  Journal Articles
• A novel antithrombotic coronary stent: lysine-poly(HEMA)-modified cobalt–chromium stent with fibrinolytic activity  Journal Articles
• A novel congenital haemostatic defect  Journal Articles
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Journal Articles
• A specific fluorescence resonance energy quenching–based biosensor for measuring thrombin activity in whole blood  Journal Articles
• AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa  Journal Articles
• Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin  Journal Articles
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Journal Articles
• Activation of blood coagulation by plaque rupture: Mechanisms and prevention  Journal Articles
• Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and d-Phe-Pro-Arg-Ch2Cl  Journal Articles
• Acute coronary syndromes: a focus on thrombin.  Journal Articles
• Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants  Journal Articles
• Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis  Journal Articles
• Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces  Journal Articles
• Advantages and limitations of the new anticoagulants  Journal Articles
• Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor  Journal Articles
• Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery  Journal Articles
• An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.  Journal Articles
• An omniphobic lubricant-infused coating produced by chemical vapor deposition of hydrophobic organosilanes attenuates clotting on catheter surfaces  Journal Articles
• Andexanet Alfa for Factor Xa Inhibitor Reversal  Journal Articles
• Andexanet Alfa for Reversal of Factor Xa Inhibitors: A Critical Review of the Evidence  Journal Articles
• Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity  Journal Articles
• Andexanet alfa for the treatment of hemorrhage  Journal Articles
• Anticoagulant Effects of Heparin in Neonatal Plasma'  Journal Articles
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Journal Articles
• Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography  Journal Articles
• Anticoagulant therapy for splanchnic vein thrombosis  Journal Articles
• Anticoagulants and Their Reversal  Journal Articles
• Anticoagulants in atrial fibrillation patients with chronic kidney disease  Journal Articles
• Anticoagulation Control with Daily Low‐Dose Vitamin K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta‐Analysis  Journal Articles
• Anticoagulation and in vitro fertilization and ovarian stimulation  Journal Articles
• Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target  Journal Articles
• Anticoagulation in patients with cerebral amyloid angiopathy  Journal Articles
• Anticoagulation therapy in neonates, children and adolescents  Journal Articles
• Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients  Journal Articles
• Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial  Journal Articles
• Antidotes for Novel Oral Anticoagulants  Journal Articles
• Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report  Journal Articles
• Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism  Journal Articles
• Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis  Journal Articles
• Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations  Journal Articles
• Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin  Journal Articles
• Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic therapy in deep vein thrombosis and pulmonary embolism  Journal Articles
• Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.  Journal Articles
• Are Ticks the Answer to Medical Device-Associated Clotting?  Journal Articles
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein  Journal Articles
• Aspirin  Journal Articles
• Assays for Measuring Rivaroxaban: Their Suitability and Limitations  Journal Articles
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Journal Articles
• Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis  Journal Articles
• Autoimmune heparin‐induced thrombocytopenia  Journal Articles
• Autologous transfusion of mediastinal drainage blood  Journal Articles
• Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time  Journal Articles
• Betrixaban (PRT054021): pharmacology, Dose Selection and Clinical Studies  Journal Articles
• Beyond heparin and warfarin: the new generation of anticoagulants  Journal Articles
• Biologic rationale for the therapeutic role of specific antithrombins  Journal Articles
• Bioregulatory roles for fibrin(ogen) on blood coagulation  Journal Articles
• Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex  Journal Articles
• Bivalirudin  Journal Articles
• Bivalirudin, thrombin and platelets: clinical implications and future directions.  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design  Journal Articles
• BloodSurf 2017: News from the blood-biomaterial frontier  Journal Articles
• By Increasing the Affinity of Heparin for Fibrin, Zn²⁺ Promotes the Formation of a Ternary Heparin–Thrombin–Fibrin Complex That Protects Thrombin from Inhibition by Antithrombin  Journal Articles
• C-reactive protein is a mediator of cardiovascular disease  Journal Articles
• Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis  Journal Articles
• Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Journal Articles
• Characterization of a Mouse Model for Thrombomodulin Deficiency  Journal Articles
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins  Journal Articles
• Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes  Conferences
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Journal Articles
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.  Journal Articles
• Coagulation Assays  Journal Articles
• Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair  Journal Articles
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Journal Articles
• Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis  Journal Articles
• Coagulopathy in a patient with nephrotic syndrome  Journal Articles
• Comparison of the Proinflammatory and Procoagulant Properties of Nuclear, Mitochondrial, and Bacterial DNA  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Journal Articles
• Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents  Journal Articles
• Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System  Journal Articles
• Contribution of Red Blood Cells to the Saturable Mechanism of Heparin Clearance  Journal Articles
• Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo  Journal Articles
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Journal Articles
• Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va  Journal Articles
• Covalent antithrombin–heparin complexes  Journal Articles
• Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets  Journal Articles
• Critical Values in the Coagulation Laboratory Results of a Survey of the North American Specialized Coagulation Laboratory Association  Journal Articles
• Current use of biologicals in thrombosis and haemostasis  Journal Articles
• DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC  Journal Articles
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Journal Articles
• Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery  Journal Articles
• Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment  Journal Articles
• Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function  Journal Articles
• Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation  Journal Articles
• Dabigatran etexilate and reduction in serum apolipoprotein B  Journal Articles
• Dabigatran monitoring made simple?  Journal Articles
• Ddavp-induced correction of prolonged bleeding time in patients with congenital platelet function defects  Journal Articles
• Decreased Thrombin Activity of Fibrin Clots Prepared in Cord Plasma Compared with Adult Plasma  Journal Articles
• Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damage  Journal Articles
• Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation  Journal Articles
• Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran  Journal Articles
• Development of the human coagulation system in the full-term infant  Journal Articles
• Development of the human coagulation system in the healthy premature infant  Journal Articles
• Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation  Journal Articles
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation  Journal Articles
• Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation  Journal Articles
• Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis  Journal Articles
• Direct Oral Anticoagulants  Journal Articles
• Direct oral anticoagulant dose selection: Challenging cases  Journal Articles
• Direct thrombin inhibitors in cardiovascular disease  Journal Articles
• Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity.  Journal Articles
• EPIDEMIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS  Journal Articles
• EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE  Journal Articles
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Journal Articles
• Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves  Journal Articles
• Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents  Journal Articles
• Effect of Drugs on Platelets and Complications of Vascular Disease  Other
• Effect of RA233 on Platelet Function In Vitro  Journal Articles
• Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients  Journal Articles
• Effect of Streptokinase on Hemostasis  Journal Articles
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Journal Articles
• Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study  Journal Articles
• Effect of endothelium on the anticoagulant activity of a covalent antithrombin-heparin complex.  Journal Articles
• Effect of gaboon viper (Bitis gabonica) venom on blood coagulation, platelets, and the fibrinolytic enzyme system  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography  Journal Articles
• Effectin vitroon platelet function of two compounds developed from the pyrimido-pyrimidines  Journal Articles
• Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters  Journal Articles
• Effects of genetic fusion of factor IX to albumin on in vivo clearance in mice and rabbits  Conferences
• Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III  Journal Articles
• Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway  Journal Articles
• Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation  Journal Articles
• Emerging anticoagulant strategies  Journal Articles
• Epidemiology and pathogenesis of venous thrombosis  Journal Articles
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Journal Articles
• Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH  Journal Articles
• Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants  Journal Articles
• Evolution of Thrombosis  Journal Articles
• Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial  Journal Articles
• Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II  Journal Articles
• Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study  Journal Articles
• Extending the pre-processing holding time of whole blood beyond 48 h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma  Journal Articles
• Extracellular DNA and histones: double‐edged swords in immunothrombosis  Journal Articles
• Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes  Journal Articles
• Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis  Journal Articles
• Factor XI Inhibition to Uncouple Thrombosis From Hemostasis  Journal Articles
• Factor XI and factor XII as targets for new anticoagulants  Journal Articles
• Factor XI inhibitors: cardiovascular perspectives  Journal Articles
• Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia  Journal Articles
• Failure of Aspirin to Prevent Atherothrombosis  Journal Articles
• Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records  Journal Articles
• Feasibility of blood conservation strategies in pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension  Journal Articles
• Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests  Journal Articles
• Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease  Journal Articles
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Journal Articles
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Journal Articles
• General mechanisms of coagulation and targets of anticoagulants (Section I)  Journal Articles
• Genetics of Coagulation: What the Cardiologist Needs to Know  Journal Articles
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Journal Articles
• Guide to Anticoagulant Therapy: Heparin  Journal Articles
• HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions  Journal Articles
• HEPARIN-BINDING PROTEINS - CONTRIBUTION TO HEPARIN REBOUND AFTER CARDIOPULMONARY BYPASS  Journal Articles
• Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis  Journal Articles
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Journal Articles
• Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review  Journal Articles
• Hemostatic alterations in cancer patients  Journal Articles
• Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial  Journal Articles
• Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.  Journal Articles
• Heparin induced thrombocytopenia  Journal Articles
• Heparin sensitivity and resistance in the neonate: An explanation  Journal Articles
• Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma  Journal Articles
• Heparin, DDAVP and the Bleeding Time  Journal Articles
• Heparin-induced Thrombocytopenia  Journal Articles
• Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Hirudin causes more bleeding than heparin in a rabbit ear bleeding model  Journal Articles
• Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice  Journal Articles
• Histidine-rich glycoprotein attenuates catheter thrombosis  Journal Articles
• Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway  Journal Articles
• Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation  Journal Articles
• Homocyst(e)ine and Cardiovascular Disease  Journal Articles
• Homocysteine-Lowering Treatment With Folic Acid, Cobalamin, and Pyridoxine Does Not Reduce Blood Markers of Inflammation, Endothelial Dysfunction, or Hypercoagulability in Patients With Previous Transient Ischemic Attack or Stroke  Journal Articles
• How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy  Journal Articles
• How do we approach thrombocytopenia in critically ill patients?  Journal Articles
• Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism  Journal Articles
• Hypercoagulability.  Journal Articles
• Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase  Journal Articles
• INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING  Journal Articles
• ISTH DIC subcommittee communication on anticoagulation in COVID‐19  Journal Articles
• Idarucizumab for Dabigatran Reversal  Journal Articles
• Idarucizumab for Dabigatran Reversal — Full Cohort Analysis  Journal Articles
• Idarucizumab for dabigatran overdose  Journal Articles
• Idiopathic gangrene in African children.  Journal Articles
• Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions  Journal Articles
• Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study  Journal Articles
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Journal Articles
• Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy  Journal Articles
• Impact of sample processing delays on plasma markers of inflammation, chemotaxis, cell death, and blood coagulation.  Journal Articles
• Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias  Journal Articles
• Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries  Journal Articles
• In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation  Journal Articles
• In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding  Journal Articles
• In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex  Journal Articles
• Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study  Journal Articles
• Incorporation of Fragment X into Fibrin Clots Renders Them More Susceptible to Lysis by Plasmin  Journal Articles
• Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa  Journal Articles
• Infection-Induced Thrombocytopenia  Journal Articles
• Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis  Journal Articles
• Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of α-thrombin  Journal Articles
• Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex  Journal Articles
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Journal Articles
• Interactions of fibrinolytic system proteins with lysine‐containing surfaces  Journal Articles
• International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement  Journal Articles
• Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex  Journal Articles
• Kinetic Analysis of a Unique Direct Prothrombinase, fgl2, and Identification of a Serine Residue Critical for the Prothrombinase Activity  Journal Articles
• Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants  Journal Articles
• Laboratory Monitoring of Oral Vitamin K Anticoagulation  Journal Articles
• Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants  Journal Articles
• Laboratory measurement of the direct oral anticoagulants  Journal Articles
• Latest medical treatment strategies for venous thromboembolism  Journal Articles
• Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development  Journal Articles
• Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis  Journal Articles
• Low molecular weight heparin  Journal Articles
• Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10  Journal Articles
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Journal Articles
• Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin  Journal Articles
• Lupus Anticoagulant Testing  Journal Articles
• Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis  Journal Articles
• MAA868 locks factor XIa in a zymogen-like state  Journal Articles
• Magnesium interrelationships in ischemic heart disease: a review  Journal Articles
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Journal Articles
• Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists  Journal Articles
• Massive transfusion  Journal Articles
• Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13  Journal Articles
• Measurement of Markers of Activated Coagulation in Antithrombin III Deficient Subjects  Journal Articles
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Journal Articles
• Medical device‐induced thrombosis: what causes it and how can we prevent it?  Journal Articles
• Mice with deleted multimerin 1 and α-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1  Journal Articles
• Microangiopathic Haemolytic Anaemia (MHA)  Journal Articles
• Microangiopathic Haemolytic Anaemia: Mechanisms of Red‐Cell Fragmentation: in Vitro Studies  Journal Articles
• Microangiopathic haemolytic anaemia: experimental production of fragmented erythrocytes in vitro.  Journal Articles
• Microvesicles: ubiquitous contributors to infection and immunity  Journal Articles
• Mimicking the fibrinolytic system on material surfaces  Journal Articles
• Modification of Polyurethane with Polyethylene Glycol–Corn Trypsin Inhibitor for Inhibition of Factor Xlla in Blood Contact  Journal Articles
• Modification of platelet function  Other
• Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant  Journal Articles
• Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT  Journal Articles
• Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups  Journal Articles
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Journal Articles
• NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study  Journal Articles
• Neonatal and childhood right atrial thrombosis  Journal Articles
• Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and Platelet-Independent Mechanisms  Journal Articles
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conferences
• New Anticoagulant Drugs  Journal Articles
• New Anticoagulants  Journal Articles
• New Concepts in Coagulation  Journal Articles
• New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors  Journal Articles
• New anticoagulants  Conferences
• New anticoagulants  Conferences
• New anticoagulants.  Journal Articles
• New anticoagulants: Moving beyond the direct oral anticoagulants  Journal Articles
• New anticoagulants: an update.  Journal Articles
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Journal Articles
• New oral anticoagulants in atrial fibrillation  Journal Articles
• New oral anticoagulants in development  Journal Articles
• No Association Between Protein C Levels and Bacteremia in Children With Febrile Neutropenia  Journal Articles
• Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment  Journal Articles
• Novel anticoagulant agents: introduction  Journal Articles
• Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants  Journal Articles
• Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms  Journal Articles
• Oral Anticoagulation Treatment in the Elderly  Journal Articles
• Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases  Journal Articles
• Orally Active Direct Thrombin Inhibitors  Journal Articles
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Journal Articles
• Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin  Journal Articles
• Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity  Journal Articles
• PROTEOLYTIC DEGRADATION OF HIGH MOLECULAR WEIGHT KININOGEN IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA  Journal Articles
• Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)  Journal Articles
• Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model  Journal Articles
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Journal Articles
• Perioperative Management of Anticoagulation  Journal Articles
• Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm  Journal Articles
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Journal Articles
• Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes  Journal Articles
• Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer  Journal Articles
• Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation  Journal Articles
• Pharmacological Actions of Sulodexide  Journal Articles
• Phosphatidylinositol 4,5-bisphosphate is selectively retained by platelet-fibrin clots formed by thrombin  Journal Articles
• Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin  Journal Articles
• Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfatea  Journal Articles
• Plasma fibronectin supports hemostasis and regulates thrombosis  Journal Articles
• Platelet PECAM-1 inhibits thrombus formation in vivo  Journal Articles
• Platelet polyphosphate: the long and the short of it  Journal Articles
• Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment  Journal Articles
• Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein  Journal Articles
• Polyurethanes bearing pendant amino acids: Fibrinogen adsorption and coagulant properties  Journal Articles
• Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: an overview  Journal Articles
• Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk  Journal Articles
• Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo  Journal Articles
• Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study  Journal Articles
• Prolonged Expression of Procoagulant Activity of Human Platelets Degranulated by Thrombin  Journal Articles
• Prolonged hemorrhagic shock does not impair regeneration of plasma coagulant masses in the rabbit  Journal Articles
• Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation  Journal Articles
• Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation  Journal Articles
• Protein C Assay Performance  Journal Articles
• Protein adsorption on polyurethane catheters modified with a novel antithrombin‐heparin covalent complex  Journal Articles
• Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy  Journal Articles
• Purification of silica‐free DNA and characterization of its role in coagulation  Journal Articles
• Quantitation of human megakaryocyte progenitors (CFU-M) in plasma clot culture by an indirect immunoperoxidase method.  Journal Articles
• RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate  Journal Articles
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Journal Articles
• Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis  Journal Articles
• Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by one stage assays with prothrombin time versus Ecarin reagents  Journal Articles
• Rationale Behind the Development of Low Molecular Weight Heparin Derivatives  Journal Articles
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Journal Articles
• Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens  Journal Articles
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse  Journal Articles
• Real-world variability in dabigatran levels in patients with atrial fibrillation: reply  Journal Articles
• Real‐world variability in dabigatran levels in patients with atrial fibrillation  Journal Articles
• Reasons for resistance to aspirin in cardiovascular disease.  Journal Articles
• Recent Advances in Thrombosis and Hemostasis – Part I  Journal Articles
• Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation  Journal Articles
• Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH  Journal Articles
• Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis  Journal Articles
• Reduced Plasminogen Binding and Delayed Activation Render γ′-Fibrin More Resistant to Lysis than γA-Fibrin  Journal Articles
• Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis  Journal Articles
• Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin  Journal Articles
• Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin  Conferences
• Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis  Journal Articles
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Journal Articles
• Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study  Journal Articles
• Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides  Journal Articles
• Reversal agents for non-vitamin K antagonist oral anticoagulants  Journal Articles
• Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study  Journal Articles
• Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• Reversible endotension associated with excessive warfarin anticoagulation  Journal Articles
• Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study  Journal Articles
• Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography  Journal Articles
• Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial  Journal Articles
• Rivaroxaban for Prevention and Treatment of Venous Thromboembolism  Journal Articles
• Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation  Journal Articles
• Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers  Journal Articles
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Journal Articles
• Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients  Journal Articles
• Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis  Journal Articles
• Setting a standard for venous thromboembolism prophylaxis  Journal Articles
• Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis?  Journal Articles
• Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall  Journal Articles
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Journal Articles
• Small Molecules Targeting GRP78 Mitigate Anti- GRP78 Autoantibody-Mediated Tissue Factor Procoagulant Activity in Cultured Endothelial Cells  Journal Articles
• Special series on challenging anticoagulation cases: Experience counts when guidelines fall short  Journal Articles
• Spotlight on animal models of acute traumatic coagulopathy: an update  Journal Articles
• Stirred, shaken, or stagnant: What goes on at the blood–biomaterial interface  Journal Articles
• Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation  Journal Articles
• Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease  Journal Articles
• Studies on East African Snakes  Journal Articles
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Journal Articles
• Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis  Journal Articles
• Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis  Journal Articles
• Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrate  Journal Articles
• Targeting Tumor Vasculature With an Oncolytic Virus  Journal Articles
• The APTT Response of Pregnant Plasma to Unfractionated Heparin  Journal Articles
• The Coagulation System in Humans  Journal Articles
• The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus  Journal Articles
• The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy  Journal Articles
• The Influence of Perioperative Coagulation Status on Postoperative Blood Loss in Complex Cardiac Surgery  Journal Articles
• The M358R variant of α 1 -proteinase inhibitor inhibits coagulation factor VIIa  Journal Articles
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Journal Articles
• The Structural Integrity of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII  Journal Articles
• The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal  Journal Articles
• The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.  Journal Articles
• The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of α1-proteinase inhibitor M358R for thrombin  Journal Articles
• The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation  Journal Articles
• The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem  Journal Articles
• The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity  Journal Articles
• The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences.  Journal Articles
• The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how?  Journal Articles
• The direct binding of human factor VII in plasma to recombinant human tissue factor  Journal Articles
• The direct thrombin inhibitor hirudin  Journal Articles
• The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae  Journal Articles
• The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. II. Protein and platelet interaction with polymer surfaces.  Journal Articles
• The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin  Journal Articles
• The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass  Journal Articles
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Journal Articles
• The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era  Journal Articles
• The haemorrhagic and antithrombotic effects of dermatan sulphate  Journal Articles
• The haemorrhagic and antithrombotic effects of dermatan sulphate.  Journal Articles
• The historical origins of modern international normalized ratio targets  Journal Articles
• The impact of the endothelial protein C receptor on thrombin generation and clot lysis  Journal Articles
• The influence of drugs upon the anticoagulant activity of heparin.  Journal Articles
• The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III  Journal Articles
• The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor  Journal Articles
• The interaction of platelets with polymer surfaces. I. Uncharged hydrophobic polymer surfaces.  Journal Articles
• The mechanism of action of thrombin inhibitors.  Journal Articles
• The multiple faces of the partial thromboplastin time APTT  Journal Articles
• The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on fibrinolysis  Journal Articles
• The onerous task of comparing treatments in inhibitor patients  Journal Articles
• The paradox of heparin‐induced thrombocytopenia  Journal Articles
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Journal Articles
• The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease  Journal Articles
• The role of microRNAs in prethrombotic status associated with coronary artery disease  Journal Articles
• The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression  Journal Articles
• The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia  Journal Articles
• The status of new anticoagulants  Journal Articles
• The temporal changes of hemostatic activity in hospitalized patients with COVID-19: a prospective observational study  Journal Articles
• The thrombogenicity of C1 esterase inhibitor (human): Review of the evidence  Journal Articles
• Thrombin Generation  Journal Articles
• Thrombin and Antithrombotics  Journal Articles
• Thrombin generation abnormalities in commonly encountered platelet function disorders  Journal Articles
• Thrombin generation and bleeding in cardiac surgery: a clinical narrative review  Journal Articles
• Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature  Journal Articles
• Thrombin structure and function  Journal Articles
• Thrombogenic Effect of High-Dose Aspirin in Rabbits  Journal Articles
• Thrombosis in children with malignancy  Journal Articles
• Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome  Journal Articles
• Thrombus stability explains the factor V Leiden paradox: a mouse model  Journal Articles
• Tissue Factor and Thrombosis Models  Journal Articles
• Tissue plasminogen activator-containing polyurethane surfaces for fibrinolytic activity  Journal Articles
• Toll-like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis.  Journal Articles
• Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies  Journal Articles
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Journal Articles
• Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users  Journal Articles
• Type 1 Plasminogen Activator Inhibitor Binds to Fibrin via Vitronectin  Journal Articles
• Understanding Thrombin and Hemostasis  Journal Articles
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Update on the Treatment of Venous Thromboembolism  Journal Articles
• Urokinase Therapy: Dosage Schedules and Coagulant Side Effects  Journal Articles
• Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.  Journal Articles
• Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation  Journal Articles
• Very severe thrombocytopenia and fragmentation hemolysis mimicking thrombotic thrombocytopenic purpura associated with a giant intracardiac vegetation infected with Staphylococcus epidermidis: Role of monocyte procoagulant activity induced by bacterial supernatant  Journal Articles
• Vitamin K antagonists in heart disease: Current status and perspectives (Section III)  Journal Articles
• Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?  Journal Articles
• Volutrauma activates the clotting cascade in the newborn but not adult rat  Journal Articles
• What can ex vivo experiments contribute to clinical haemostasis management?  Journal Articles
• When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant?  Journal Articles
• Why Did Your Mother Reject You? Immunogenetic Determinants of the Response to Environmental Selective Pressure Expressed at the Uterine Level  Journal Articles
• Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure  Journal Articles
• Zinc: An important cofactor in haemostasis and thrombosis  Journal Articles
• c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency  Journal Articles
• γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo  Journal Articles